Dr. Massimo Cristofanilli, MD is an oncologist in Chicago, Illinois. He is currently licensed to practice medicine in Illinois and Pennsylvania.
He is an expert in the research and management of hormone-receptor positive metastatic breast cancer and IBC. He is a pioneer in liquid biopsy including CTCs and ctDNA research and clinical applications. He leads the Precision Medicine program at the Lurie Cancer Center, NU aimed at application of NGS and omics for patients' care.